GENENTECH GENE SAYS FDA TO REVIEW TPA SOUTH SAN FRANCISCO April Genentech Inc said Activase its tissue plasminogen activator will be reviewed at the a regularly scheduled May meeting of the Food and Drug Administration s cardiorenal advisory committee Reuter